SMART Trial: Community Stigma Reduction

The goal of this project is to engage community members from two low-income African American communities (N=200) in a survey study that assesses stigma toward those with Opioid Use Disorder (OUD). Those from the intervention community will be subject to a stigma reduction campaign via billboards. Those from the control community will not. Stigma will be re-assessed following the period of the campaign.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Opioid-use Disorder Behavior Chemically-Induced Disorders Mental Disorders Narcotic-Related Disorders Opioid-Related Disorders Social Behavior Social Stigma Stigma, Social Substance-Related Disorders

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Tennessee Health Science Center

Memphis, Tennessee, 38163, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Identify as African American or Mixed race
Reside in Frayser or Orange Mound Communities
Access to telephone for follow-up assessment

Exclusion criteria

Unable to understand consent procedures

Treatment and study plan

Opioid Use Disorder Stigma Reduction

Behavioral

Billboards with destigmatizing language regarding opioid use disorder placed in the community.

Primary outcomes

Stigma score

Time frame: Change from baseline stigma score at 8 weeks

Pre- and post-intervention stigma assessments using the Exposure to Drug Users Index, Drug Use Stigmatization Scale, and the Stigma of Drug Users Scale

Sponsors and collaborators

Lead sponsor

Karen Derefinko, PhD

Other

Collaborators

National Center for Complementary and Integrative Health (NCCIH)

Registry information

Official study title

SMART Trial: Reducing Stigma Towards Opioid Use Disorder at the Community Level

Important dates

Study start: 2021
Primary completion: 2021
Study completion: 2021
First posted: Oct 12, 2021
Registry last updated: Mar 18, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed